Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Radian Group Files Q3 2026 Earnings Results 8-K

Radian Group Inc. filed a Current Report on Form 8-K on November 5, 2026, reporting that it issued a news release on November 4, 2026, announcing its financial results for the quarter ended September 30, 2026.

Aditi Sarkar | 05 November 2026

Adagio Medical 1-for-30 Reverse Stock Split Effective Nov. 6

Adagio Medical Holdings, Inc. filed a Form 8-K on November 5, 2026, disclosing that it filed a Certificate of Amendment with the State of Delaware on November 4, 2026 to effect a one-for-thirty reverse stock split of its common stock, effective at 5:00 p.m. …

Aakashdeep | 05 November 2026

Eagle Bancorp Montana Files Investor Presentation, November 2026

Eagle Bancorp Montana, Inc. filed a Form 8-K on November 5, 2026, disclosing under Item 7.01 (Regulation FD) that its executive officers will present to institutional investors during the first week of November 2026.

Anjali Anand | 05 November 2026

Lifetime Brands Raises Share Buyback Capacity to $20M

Lifetime Brands, Inc. filed a Form 8-K on November 5, 2026, disclosing a Board-authorized increase to its share repurchase program and announcing third-quarter 2026 financial results via press release.

Nitish Kishor | 05 November 2026

Korsana Biosciences Q3 2026: $456M Cash After IPO

Korsana Biosciences, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting a net loss of $46.4 million for the third quarter and cash and cash equivalents of $456.2 …

Aditi Sarkar | 05 November 2026

Jerash Holdings Declares $0.05 Quarterly Dividend Nov 2026

Jerash Holdings (US), Inc. filed a Form 8-K on November 5, 2026, disclosing that its board of directors declared a regular quarterly cash dividend of $0.05 per share of common stock, payable on or about November 23, 2026.

Vinay Lochav | 05 November 2026

Interpace Biosciences Lists Common Stock on Nasdaq

Interpace Biosciences, Inc. filed a Form 8-A12B on November 5, 2026, to register its common stock, par value $0.01 per share, for listing on The Nasdaq Stock Market LLC.

Aakashdeep | 05 November 2026

Palvella Therapeutics Files Q3 2026 Report

Palvella Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026.

Vinay Lochav | 05 November 2026

Bryan T. Vaughn Sells 306 Labcorp Shares at $353.70

A Form 4 filed on November 5, 2026 reports that Bryan T. Vaughn, EVP and President, Diagnostics at Labcorp Holdings Inc., sold 306 shares of common stock on November 3, 2026 under a Rule 10b5-1 trading plan.

Manish Choudhary | 05 November 2026

SCYNEXIS Posts $22.4M Net Loss for Nine Months Ended Sept 2026

SCYNEXIS, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, and reporting a net loss of $22.360 million for the nine months ended on that date.

Shwetambri Chauhan | 05 November 2026
Support

Hi! How can we help you today?

Loading…